{"id":237102,"date":"2025-10-19T20:56:24","date_gmt":"2025-10-19T20:56:24","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/237102\/"},"modified":"2025-10-19T20:56:24","modified_gmt":"2025-10-19T20:56:24","slug":"jj-lays-out-plan-to-splinter-orthopedics-business-into-separate-company-2","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/237102\/","title":{"rendered":"J&J lays out plan to splinter orthopedics business into separate company"},"content":{"rendered":"

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business<\/a>.<\/p>\n

The health care giant said Tuesday that it will separate its orthopedics business into a standalone company known as DePuy Synthes. The move leaves J&J focused on its pharmaceutical and MedTech segments, which make prescription drugs, contact lenses and technology to treat cardiovascular disease and help with surgeries.<\/p>\n

The orthopedics business will be led by Namal Nawana, a former CEO of the medical technology business Smith & Nephew, which makes products for sports medicine and wound management and also focuses on orthopedics.<\/p>\n

J&J\u2019s orthopedics business pulled in more than $9 billion in sales last year. But the company said the split will help it focus on higher-growth areas.<\/p>\n

The company expects to complete the move over the next 18 to 24 months.<\/p>\n

J&J announced in November, 2021, that it would turn its consumer health business, which makes Band-Aids, Listerine and Tylenol into a separate company that later became known as Kenvue.<\/p>\n

New Brunswick, New Jersey-based Johnson & Johnson also reported on Tuesday better-than-expected third-quarter earnings and reaffirmed its adjusted earnings guidance for the year.<\/p>\n

Company shares slipped more than $2 to $188.74 in premarket trading. The shares have already climbed more than 30% so far this year. <\/p>\n","protected":false},"excerpt":{"rendered":"Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.…\n","protected":false},"author":2,"featured_media":237103,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[28,97,252,2601,253,851,2918,11156,16450,243,1997,1104,2824,5313],"class_list":["post-237102","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-business","tag-health","tag-health-care","tag-health-care-industry","tag-healthcare","tag-inc","tag-johnson-johnson","tag-kenvue","tag-medical-technology","tag-medication","tag-new-jersey","tag-pain-management","tag-prescription-drugs","tag-surgery"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/237102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=237102"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/237102\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/237103"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=237102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=237102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=237102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}